Literature DB >> 12168092

Discovery of over-expressed genes and genetic alterations in breast cancer cells using a combination of suppression subtractive hybridization, multiplex FISH and comparative genomic hybridization.

Dong Xie1, Anna Jauch, Carl W Miller, Claus R Bartram, H Phillip Koeffler.   

Abstract

To identify genes that are involved in breast cancer, suppression subtractive hybridization (SSH) was utilized to construct a breast cancer subtracted library. Differential screening of the library isolated 28 genes which by Northern analysis were highly expressed in the breast cancer cell line MDA-MB-231 compared to the normal breast cell line MCF12A. Sequence analysis revealed that 15 clones coded for previously described genes such as SNAP43, Cyr61, Thymosin beta4, tra1, elongation factor 1alpha, BSF-2/IL6, BiP, and GDP/GTP exchange protein. The remaining 13 clones did not match sequences in GenBank/EMBL database, indicating that they may be novel genes. SNAP43, a subunit of the TBP-TAF complex, was expressed 20-fold higher in MDA-MB-231 compared to MCF12A and several breast cancer cell lines, implying that SNAP43 may be involved in tumorigenesis of a specific subset of breast cancers. Amplification of SNAP43 was not found by Southern analysis. However, genetic alterations of MDA-MB-231 included a deletion of chromosome 14 with a reciprocal translocation t(6;14) and two additional translocations [t(12;14) and t(14;15)] as determined by fluorescent in situ hybridization (FISH) with YAC 823G8 located at chromosome 14q23 which contained SNAP43. Because of the numerous alterations observed by FISH in MDA-MB-231, we further explored the genetic abnormalities in this breast cancer cell line using multiplex FISH (M-FISH) and comparative genomic hybridization (CGH). These cells were replete with numerous complex structural rearrangements and had DNA copy-number imbalances involving multiple chromosomes including gains on chromosomes 2p, 2q31-q32, 3p14-pter, 5q, 6p, 7q36-qter, 11, 14q21-q24, 17p11.2-pter, 17q21-qter, 19, 20, Xp11-q13 and losses on chromosomes 4pter-q32, 8p, 9p21-p24, 10q26-qter, 16p13-pter, 18q12-qter, 22, Xp11.3-p22.1, Xq13-qter. In summary, SSH revealed a number of genes that were either novel or previously not associated with breast cancer. In addition, we found that breast cancer cells abounded with abnormalities as observed by M-FISH and CGH. Together, these results may facilitate defining the genetic alterations associated with breast cancer progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12168092

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  17 in total

Review 1.  Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesis.

Authors:  Sarah Thornton; Nisha Anand; Dan Purcell; Jonathan Lee
Journal:  J Mol Med (Berl)       Date:  2003-08-01       Impact factor: 4.599

2.  Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population.

Authors:  Sebastian C J Steiniger; Judith A Coppinger; Jörg A Krüger; John Yates; Kim D Janda
Journal:  Stem Cells       Date:  2008-09-18       Impact factor: 6.277

3.  Molecular cloning and structural characterization of the functional human thymosin beta4 gene.

Authors:  Shu-Ping Yang; Hui-Ju Lee; Yeu Su
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

Review 4.  Roles of thymosins in cancers and other organ systems.

Authors:  Changyi Chen; Min Li; Hui Yang; Hong Chai; William Fisher; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

5.  Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.

Authors:  Ivan Martinez; Jun Wang; Kenosha F Hobson; Robert L Ferris; Saleem A Khan
Journal:  Eur J Cancer       Date:  2006-10-31       Impact factor: 9.162

6.  Chromosome 9 arm-specific telomere length and breast cancer risk.

Authors:  Yun-Ling Zheng; Christopher A Loffredo; Peter G Shields; Sahar M Selim
Journal:  Carcinogenesis       Date:  2009-06-17       Impact factor: 4.944

7.  Genomic signatures of breast cancer metastasis.

Authors:  V Urquidi; S Goodison
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

8.  Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.

Authors:  Esteban Ballestar; Maria F Paz; Laura Valle; Susan Wei; Mario F Fraga; Jesus Espada; Juan Cruz Cigudosa; Tim Hui-Ming Huang; Manel Esteller
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

9.  Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers.

Authors:  Masamitsu Onda; Mitsuru Emi; Hisaki Nagai; Takemitsu Nagahata; Kouji Tsumagari; Takashi Fujimoto; Futoshi Akiyama; Goi Sakamoto; Masujirou Makita; Fujio Kasumi; Yoshio Miki; Toshihiro Tanaka; Tatsuhiko Tsunoda; Yusuke Nakamura
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-03       Impact factor: 4.553

10.  Identification of a novel binding protein of FAT10: eukaryotic translation elongation factor 1A1.

Authors:  Xin Yu; Xiuxia Liu; Tiande Liu; Kui Hong; Jun Lei; Rongfa Yuan; Jianghua Shao
Journal:  Dig Dis Sci       Date:  2012-05-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.